Skip to Content
Clinical Assistant Professor of Dermatology
Office: 40033 PFP200 Hawkins DriveIowa City, Iowa 52242
Office Phone: 319-356-2856
MD/PhD, Washington Unviersity School of MedicineBS, Microbiology, University of Iowa Carver College of Medicine
Internship, University of Iowa Carver College of MedicineResidency, Columbia University School of MedicineFellowship, Procedural Dermatology & Mohs Surgery
New York State LicenseAdvanced Cardiac Life Support, American Heart AssociationDiplomate, American Board of DermatologyFDNY Certificate of Fitness for supervising non-production chemical laboratories
Dr. Johnson received a Bachelor of Science degree in microbiology with Highest Honors at the University of Iowa and then completed her medical education and doctorate in immunology at Washington University School of Medicine in St. Louis. After her research on the molecular pathways immune cells use to fight cancer, Dr. Johnson decided to focus on patients with a high risk of developing skin cancer. Following an internship in internal medicine in Boston and training in dermatology at the New York University School of Medicine, she completed a two-year fellowship in Mohs micrographic surgery and procedural dermatology at the Columbia University School of Physicians and Surgeons/New York-Presbyterian Hospital. While in training, she initiated one of the first research projects assessing patient safety and quality of care in the field of dermatology. Dr. Johnson’s collective research interests in cutaneous oncology, surgical reconstruction, and patient safety continue to grow. She is a published author of several peer-reviewed journal articles and book chapters, and is a frequent lecturer at universities and national meetings of multiple medical specialty associations.
2014. Johnson-Jahangir H,
Modified flap design for symmetric reconstruction of the apical triangle of the upper lip.
2012 June. 38(6):905-11.
Advances in management of dermatofibrosarcoma protuberans.
2011 April. 29(2):191-200.
Patient Safety in Dermatology. An online update.
2011 January. Johnson-Jahangir H,
Using imatinib as neoadjuvant therapy in dermatofibrosarcoma protuberans: potential pluses and minuses.
J Natl Compr Canc Netw.
2010 August. 8(8):881-5.
Patient safety: Part II. Opportunities for improvement in patient safety.
J Am Acad Dermatol.
2009 August. 61(2):193-205; quiz 206.
Date Last Modified: 09/18/2014 -
Copyright © 2011 The University of Iowa. All Rights Reserved.